The store will not work correctly when cookies are disabled.
(1R,4R,5R)-1,4,5-trihydroxy-3-(thiophen-2-yl)cyclohex-2-enecarboxylic acid
ID: ALA1823557
PubChem CID: 24857914
Max Phase: Preclinical
Molecular Formula: C11H12O5S
Molecular Weight: 256.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)[C@]1(O)C=C(c2cccs2)[C@@H](O)[C@H](O)C1
Standard InChI: InChI=1S/C11H12O5S/c12-7-5-11(16,10(14)15)4-6(9(7)13)8-2-1-3-17-8/h1-4,7,9,12-13,16H,5H2,(H,14,15)/t7-,9-,11+/m1/s1
Standard InChI Key: WVCLOPJCJZRGSN-ZOFUNIGCSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
-1.8708 -7.4625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4542 -8.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0418 -7.4600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1625 -8.5958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1625 -9.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4505 -9.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7385 -9.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7385 -8.5958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2169 -7.4575 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4565 -6.7468 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0246 -9.8344 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4505 -10.6542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8782 -9.8348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6574 -9.5640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1557 -10.2216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6842 -10.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8947 -10.6595 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 9 1 0
2 3 1 1
3 10 2 0
4 5 2 0
7 11 1 1
6 12 1 6
13 14 2 0
4 2 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 2 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 1 0
5 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 256.28 | Molecular Weight (Monoisotopic): 256.0405 | AlogP: 0.07 | #Rotatable Bonds: 2 |
Polar Surface Area: 97.99 | Molecular Species: ACID | HBA: 5 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.94 | CX Basic pKa: ┄ | CX LogP: -0.17 | CX LogD: -3.36 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.60 | Np Likeness Score: 0.57 |
References
1. Tizón L, Otero JM, Prazeres VF, Llamas-Saiz AL, Fox GC, van Raaij MJ, Lamb H, Hawkins AR, Ainsa JA, Castedo L, González-Bello C.. (2011) A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors., 54 (17): [PMID:21780742] [10.1021/jm2006063] |